| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4e5aca95e88bbf672b211a9427a5b8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1973-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1976-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-1442772-A |
| titleOfInvention |
Inhibition of leukaemia utilizing 5-methyl-tetrahydrohomofolate |
| abstract |
1442772 Compositions containing 5-methyltetrahydrohomofolic acid UNITED STATES OF AMERICA GOVERNMENT OF 9 July 1973 [24 July 1972] 32528/73 Heading A5B A composition for treatment of leukaemia in mammals comprises 5-methyltetrahydrohomofolic acid or an alkali metal salt thereof or a pharmaceutically acceptable acid addition salt or amine salt thereof together with a pharmaceutically acceptable carrier containing sodium ascorbate, cysteine, mercaptoethanol, mercaptopropanol or Clelands reagent. |
| priorityDate |
1972-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |